Crimean News
News of Crimea - The latest news of Crimea today. Events and incidents, economics and finance, sports, science, culture, resorts, society and politics in Crimea. Crimean news for the last day. Sevastopol News
Healthcare of Sevastopol: the list of vital and essential medications has been supplemented

Healthcare of Sevastopol: the list of vital and essential medications has been supplemented

CrimeaPRESS reports:

In June, the order of the Government of the Russian Federation on changes to the list of vital and essential drugs (VED) came into force. In this regard, at a meeting of the Government of Sevastopol, chaired by Governor Mikhail Razvozhaev, they considered a resolution to amend the Territorial Program of State Guarantees of free medical care to citizens in the city for 2024 and for the full period 2025-2026.

The changes affected the list of vital and essential medications. It was brought into compliance in order to comply with the provisions of federal law. Now it has been supplemented with new drugs.

It includes three combination drugs that are used to treat patients with various viral and bacterial infections and infectious and inflammatory diseases, and two new drugs needed by patients with multiple sclerosis— the press service of the Government of Sevastopol quotes the director of the health department Vitaly Denisov.

The list included:

  • Cefetim + sulbactam, powder for the preparation of a solution for intravenous and intramuscular administration;
  • Lamivudine + Phosphazide, tablets;
  • Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-argine succinate, lyophilisate for the preparation of solution for intramuscular administration and inhalation solution;
  • Sampeginterferon beta-1a, solution for intramuscular administration;
  • Divosilimab, concentrate for solution for infusion.

source: press service of the Government of Sevastopol

Crimea news | CrimeaPRESS: latest news and main events

Find out more:  Sevastopol Police: recruitment of candidates for junior and middle command positions

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy